Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment

Anticancer Agents Med Chem. 2023;23(7):765-778. doi: 10.2174/1871520622666220831124321.

Abstract

Historically, natural plant-derived drugs received a great impact of consideration in the treatment of several human-associated disorders. Cancer is a devastating disease and the second most cause of mortality. Sanguinarine (SANG), a naturally isolated plant alkaloidal agent, possesses chemo-preventive effects. Several studies have revealed that SANG impedes tumor metastasis and development by disrupting a wide range of cell signaling pathways and its molecular targets, such as BCL-2, MAPKs, Akt, NF-κB, ROS, and microRNAs (miRNAs). However, its low chemical stability and poor oral bioavailability remain key issues in its use as a medicinal molecule. A novel method (e.g., liposomes, nanoparticles, and micelles) and alternative analogs provide an exciting approach to alleviate these problems and broaden its pharmacokinetic profile. Cancer-specific miRNA expression is synchronized by SANG, which has also been uncertain. In this critical study, we review the utilization of SANG mimics and nano-technologies to improve its support in cancer. We focus on recently disclosed studies on SANG anti-cancer properties.

Keywords: Sanguinarine; cancer; chemo-preventive effects; molecular target; nanoparticle; natural agent.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Benzophenanthridines / chemistry
  • Benzophenanthridines / pharmacology
  • Humans
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology
  • Isoquinolines / therapeutic use
  • MicroRNAs* / genetics
  • Neoplasms* / drug therapy
  • Neoplasms* / prevention & control
  • Signal Transduction

Substances

  • sanguinarine
  • Benzophenanthridines
  • Antineoplastic Agents
  • Isoquinolines
  • MicroRNAs